A COMPARATIVE STUDY ON THE SAFETY AND EFFICACY OF TOPICAL BIMATOPROST WITH TIMOLOL MALEATE IN GLAUCOMA PATIENTS

被引:0
|
作者
Polagani, Padma [1 ]
Maddikunta, Sridhar Venkat [2 ]
Balakrishna, Namala [2 ]
Kondaveti, Souris [2 ]
机构
[1] Kakatiya Med Coll, Dept Pharmacol, Warangal, Telangana, India
[2] Osmania Med Coll & Hosp, Dept Pharmacol, Hyderabad, Telangana, India
关键词
IOP; PACG; POAG; Bimatoprost; Timolol Maleate;
D O I
10.14260/jemds/2016/670
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Glaucoma is a group of disorders characterized by increase in Intraocular Pressure OOP), which can damage the optic nerve and if untreated can lead to gradual peripheral vision loss and irreversible blindness. Glaucoma classified into primary and secondary glaucoma. Primary glaucoma has two types Primary Open Angle Glaucoma (POAG) and Primary Angle Closure Glaucoma (PACG). Glaucoma is the second leading cause of blindness. Worldwide, it is estimated that about 66.8 million people have visual impairment from glaucoma with 6.8 million suffering from blindness. AIMS AND OBJECTIVE To assess the level of IOP reduction of bimatoprost with timolol maleate and its statistical analysis. To compare the IOP lowering efficacy of bimatoprost with timolol maleate. To study the adverse drug reaction profiles of both the drugs. MATERIALS AND METHODS This study was designed to compare the efficacy and safety of topical anti-glaucoma drugs, Bimatoprost (0.03%) and Timolol maleate (0.5%) in patients with POAG attending at Regional Eye Hospital, Warangal. RESULTS In this study mean reduction of IOP at 2 wks., 6 wks., 12 wks., 24 wks. were 6.60 mmHg (23.21%), 9.6 mmHg (33.76%), 10.00 mmHg (38.68%), 11.20 mmHg (39.39%) for Bimatoprost and 4.20 mmHg (15.07%), 6.24% mmHg (23.39%), 7.36 mmHg (25.91%) and 7.64 mmHg (26.56%) for Timolol group respectively. STATISTICAL METHOD Student's 't' test was used for analysis of results. CONCLUSION Bimatoprost 0.03% ophthalmic solution was highly efficacious, well tolerated, systemically safe and minimal ocular side effects and less drug withdraw. It can be used as first line therapy to treat cases of POAG to reduce IOP. The only limitation for its use is regarding its cost. The topical bimatoprost preparations are expensive when compared to the topical Timolol maleate. But considering the reduction in IOP, the modifiable factor for preventing the progression of optic nerve head damage and preservation of visual function hence increase the quality of vision and life.
引用
收藏
页码:2974 / 2979
页数:6
相关论文
共 50 条
  • [1] A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients
    Jothi, R.
    Ismail, A. M.
    Senthamarai, R.
    Pal, Siddhartha
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 362 - 365
  • [2] Efficacy and Safety of Intraocular Pressure-Lowering Agents Bimatoprost and Timolol Maleate in Glaucoma
    Chen, Lin
    Zeng, Xiaoli
    Huang, Xuewen
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (02) : 179 - 186
  • [3] The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP
    Suzan Guven Yilmaz
    Cumali Degirmenci
    Yunus Emre Karakoyun
    Emil Yusifov
    Halil Ates
    International Ophthalmology, 2018, 38 : 1425 - 1431
  • [4] The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP
    Yilmaz, Suzan Guven
    Degirmenci, Cumali
    Karakoyun, Yunus Emre
    Yusifov, Emil
    Ates, Halil
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (04) : 1425 - 1431
  • [5] TIMOLOL MALEATE - EFFICACY AND SAFETY
    ZIMMERMAN, TJ
    KASS, MA
    YABLONSKI, ME
    BECKER, B
    ARCHIVES OF OPHTHALMOLOGY, 1979, 97 (04) : 656 - 658
  • [6] Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertension
    Martinez, Antonio
    Sanchez, Manuel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (01) : 137 - 143
  • [7] Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination
    Day, DG
    Sharpe, ED
    Beischel, CJ
    Jenkins, JN
    Stewart, JA
    Stewart, WC
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2005, 15 (03) : 336 - 342
  • [8] Efficacy and Safety of Switching from Topical Latanoprost to Bimatoprost in Patients with Normal-Tension Glaucoma
    Sato, Shino
    Hirooka, Kazuyuki
    Baba, Tetsuya
    Mizote, Masanori
    Fujimura, Takashi
    Tenkumo, Kaori
    Ueda, Hirokazu
    Shiraga, Fumio
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (05) : 499 - 502
  • [9] Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension
    Ling Zhihong
    Zhang Mingchang
    Hu Yizhen
    Yin Zhengqin
    Xing Yiqiao
    Fang Aiwu
    Ye Jian
    Chen Xiaoming
    Liu Dachuan
    Wang Yusheng
    Sun Wei
    Dong Yangceng
    Sun Xinghuai
    CHINESE MEDICAL JOURNAL, 2014, 127 (05) : 905 - 910
  • [10] Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension
    Ling Zhihong
    Zhang Mingchang
    Hu Yizhen
    Yin Zhengqin
    Xing Yiqiao
    Fang Aiwu
    Ye Jian
    Chen Xiaoming
    Liu Dachuan
    Wang Yusheng
    Sun Wei
    Dong Yangceng
    Sun Xinghuai
    中华医学杂志(英文版), 2014, 127 (05) : 905 - 910